{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:58:37Z","timestamp":1773691117364,"version":"3.50.1"},"reference-count":14,"publisher":"BMJ","issue":"1","funder":[{"name":"Grant-in-Aid for Clinical Research from the National Hospital Organization"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2019,5,9]]},"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Standard treatment for nodular\/bronchiectatic <jats:italic>Mycobacterium avium<\/jats:italic> complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide, ethambutol and rifampicin is recommended, but a daily treatment regimen is recommended in Japan. To date, no randomised controlled study directly comparing intermittent treatment with daily treatment has been performed. The purpose of this study is to investigate the usefulness of intermittent treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>A total of 140 patients diagnosed with NB MAC-LD in Japan will be randomly assigned, in a 1:1 ratio, to intermittent treatment group or daily treatment group, and three-drug combination therapy with clarithromycin, rifampicin and ethambutol will be continued for 1 year. The primary endpoint is the proportion of patients requiring modification of the initial treatment regimen. Secondary endpoints are adverse events, sputum culture conversion, time to sputum culture conversion, improvement of chest CT findings, change in health-related quality of life score and development of clarithromycin resistance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>This trial was approved by the National Hospital Organisation Review Board for Clinical Trials (Headquarters). The results of this study will be reported at a society meeting or published in a peer-review journal.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2019-000434","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T06:45:15Z","timestamp":1559285115000},"page":"e000434","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular\/bronchiectatic <i>Mycobacterium avium<\/i> complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol"],"prefix":"10.1136","volume":"6","author":[{"given":"Taku","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-4953","authenticated-orcid":false,"given":"Hiroya","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Kogure","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Sekimizu","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko M","family":"Saito","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"key":"2025083112253230000_6.1.e000434.1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2025083112253230000_6.1.e000434.2","doi-asserted-by":"crossref","unstructured":"Koh W-J , Moon SM , Kim S-Y , et al . Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur Respir J 2017;50.doi:10.1183\/13993003.02503-2016","DOI":"10.1183\/13993003.02503-2016"},{"key":"2025083112253230000_6.1.e000434.3","first-page":"29","article-title":"Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease--2012 revised version","volume":"88","year":"2013","journal-title":"Kekkaku"},{"key":"2025083112253230000_6.1.e000434.4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx311"},{"key":"2025083112253230000_6.1.e000434.5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chest.2018.01.024","article-title":"Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review","volume":"153","author":"Diel","year":"2018","journal-title":"Chest"},{"key":"2025083112253230000_6.1.e000434.6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix517"},{"key":"2025083112253230000_6.1.e000434.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2025083112253230000_6.1.e000434.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1531OC"},{"key":"2025083112253230000_6.1.e000434.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209729"},{"key":"2025083112253230000_6.1.e000434.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2538"},{"key":"2025083112253230000_6.1.e000434.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1545OC"},{"key":"2025083112253230000_6.1.e000434.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-450OC"},{"key":"2025083112253230000_6.1.e000434.13","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201604-246OC"},{"key":"2025083112253230000_6.1.e000434.14","unstructured":"The Government of Japan . National action plan on antimicrobial resistance (AMR) 2016-2020. Available: http:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf [Accessed 4 Feb 2019]."}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2019-000434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:25:40Z","timestamp":1756668340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2019-000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,5,30]]},"published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1136\/bmjresp-2019-000434"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2019-000434","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}